Related Experiment Videos
[Auto-immune hypoglycemic syndrome induced by pyritinol]
B Faguer de Moustier1, M Burgard, C Boitard
1Clinique de Diabétologie, Hôtel-Dieu, Paris.
Diabete & Metabolisme
|July 1, 1988
Summary
Auto-immune hypoglycemia, marked by low blood sugar and anti-insulin antibodies, can occur without prior insulin use. A case study highlights Pyritinol
Area of Science:
- Endocrinology
- Immunology
- Pharmacology
Background:
- Auto-immune hypoglycemia is a rare condition characterized by hypoglycemia and the presence of anti-insulin antibodies in individuals without a history of exogenous insulin administration.
- The syndrome has been primarily reported in Japanese populations, often associated with the use of sulfhydryl-containing drugs.
Observation:
- A Caucasian female patient treated with Pyritinol for rheumatoid polyarthritis developed severe spontaneous hypoglycemia.
- Her serum exhibited anti-insulin antibodies, and antibody levels decreased significantly upon drug discontinuation.
- This case suggests a potential link between Pyritinol and the development of auto-immune hypoglycemia.
Findings:
- Advanced characterization techniques for circulating insulin and antibodies can help differentiate auto-immune hypoglycemia from factitious hypoglycemia caused by self-administration of animal insulin.
- The findings suggest that structural abnormalities in the insulin molecule may contribute to the pathogenesis of this syndrome.
- The precise mechanism by which anti-insulin auto-antibodies induce hypoglycemia and the specific predisposition conferred by sulfhydryl-containing drugs remain unclear.
Implications:
- Understanding the mechanisms underlying auto-immune hypoglycemia is crucial for accurate diagnosis and effective management.
- Further research into drug-induced auto-immunity may reveal new therapeutic targets and preventative strategies.
- This case underscores the importance of considering drug-induced side effects in the differential diagnosis of spontaneous hypoglycemia.